Introduction: Expanding the horizons in unstable coronary artery disease.
Chesebro
J H
JH
Cardiovascular Institute, Mount Sinai Hospital, New York 10029, USA. jchesebro@smtplink.mssm.edu
Verheugt
F W
FW
D000789:Angina, Unstable / Q000517:prevention & control; D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D003328:Coronary Thrombosis / Q000517:prevention & control; D019468:Disease Management; D004359:Drug Therapy, Combination; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin